The Role of Urinary Fibronectin and Telomerase in Patients with Superficial Bladder Cancer after Transurethral Resection Treated with BCG

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Unknown venue

• Publication date

  2010-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.21608/besps.2010.36166
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Predictive value of telomerase reverse transcriptase expression in patients with high risk superficial bladder cancer treated with adjuvant BCG immunotherapy

  2009cited by this paper
• Differential Induction in Telomerase Activity among Bladder Cancer Patients and Controls on γ-Radiation

  2007cited by this paper
• Early-stage bladder cancer surveillance does not improve survival if high-risk patients are permitted to progress to muscle invasion.

  2007cited by this paper
• The diagnosis and staging of bladder cancer: from RBCs to TURs.

  2006cited by this paper
• Relevance of Urine Telomerase in the Diagnosis of Bladder Cancer

  2006cited by this paper
• Early bladder cancer: concept, diagnosis, and management

  2006cited by this paper
• Elevation of telomerase activity positively correlates to poor prognosis of patients with non-small cell lung cancer.

  2006cited by this paper
• 608: Comparison of Four Tumor Markers for Urinary Bladder Cancer- Tissue Polypeptide Antigen (TPA), HER-2/NEU (ERB B2), Urokinase-Type Plasminogen Activator Receptor (UPAR), and TP53 Mutation

  2005cited by this paper
• The role of urinary cytology for detection of bladder cancer.

  2005cited by this paper
• Catalytic subunit of human telomerase reverse transcriptase is an independent predictor of survival in patients undergoing curative resection of hepatic colorectal metastases: a multicenter analysis.

  2005cited by this paper
• hTERT antagonizes p53-induced apoptosis independently of telomerase activity

  2005cited by this paper
• Urine telomerase: an important marker in the diagnosis of bladder cancer.

  2004cited by this paper
• The Clinical Significance of Molecular Markers to Bladder Cancer

  2004cited by this paper
• A prospective evaluation of the diagnostic and potential prognostic utility of urinary human telomerase reverse transcriptase mRNA in patients with bladder cancer.

  2004cited by this paper
• Telomere Erosion in Memory T Cells Induced by Telomerase Inhibition at the Site of Antigenic Challenge In Vivo

  2004cited by this paper
• Cellular fibronectin in patients with transitional cell carcinoma of the bladder

  2003cited by this paper
• Sufficient prophylactic efficacy with minor adverse effects by intravesical instillation of low‐dose bacillus Calmette‐Guérin for superficial bladder cancer recurrence

  2003influential reference
• Telomerase as tumor marker.

  2003cited by this paper
• Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses.

  2003cited by this paper
• Tumor markers in the diagnosis of primary bladder cancer. A systematic review.

  2003cited by this paper
• Evaluation and follow-up strategies for superficial bladder cancer.

  2003cited by this paper
• Do prognostic parameters of remission versus relapse after Bacillus Calmette-Guérin (BCG) immunotherapy exist?. analysis of a quarter century of literature.

  2003cited by this paper
• Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.

  2002cited by this paper
• Fibronectin at a glance

  2002cited by this paper
• A study comparing various non‐invasive methods of detecting bladder cancer in urine

  2002cited by this paper
• Telomerase: Its clinical relevance in the diagnosis of bladder cancer

  2002cited by this paper
• Telomerase detection in body fluids.

  2002cited by this paper
• Cytologic features of the nested variant of urothelial carcinoma

  2002cited by this paper
• Nucleolar localization of hTERT protein is associated with telomerase function.

  2002cited by this paper
• BCG effects on telomerase activity in bladder cancer cell lines

  2002influential reference
• Bilharziasis of the genitourinary tract

  2002influential reference
• Bladder cancer: epidemiology, diagnosis, and management.

  2002cited by this paper
• Telomerase activity and patient survival after surgery for gastric and oesophageal cancer

  2001cited by this paper
• Bladder cancer in Africa: update.

  2001cited by this paper
• The use of telomerase activity for the detection of prostatic cancer cells after prostatic massage.

  2001cited by this paper
• Does early cystectomy improve the survival of patients with high risk superficial bladder tumors?

  2001cited by this paper
• Bladder cancer 2000: molecular markers for the diagnosis of transitional cell carcinoma.

  2001cited by this paper
• Planning cancer prevention strategies based on epidemiologic characteristics: an Egyptian example.

  2001cited by this paper
• Telomerase and human tumorigenesis.

  2000cited by this paper
• The role and impact of pathology review on stage and grade assessment of stages Ta and T1 bladder tumors: a combined analysis of 5 European Organization for Research and Treatment of Cancer Trials.

  2000cited by this paper
• Telomeres, telomerase, and cancer: life on the edge of genomic stability

  2000cited by this paper
• Quantitative measurement of telomerase reverse transcriptase (hTERT) mRNA in urothelial cell carcinomas

  2000influential reference
• Telomerase activity as a potential marker in preneoplastic bladder lesions

  2000cited by this paper
• A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma.

  2000cited by this paper
• Evaluation of two new urinary tumor markers: bladder tumor fibronectin and cytokeratin 18 for the diagnosis of bladder cancer.

  2000cited by this paper
• Low dose bacillus Calmette-Guerin for carcinoma in situ of the bladder: long-term results.

  2000cited by this paper
• Primary superficial bladder cancer risk groups according to progression, mortality and recurrence.

  2000cited by this paper
• Comparison of screening methods in the detection of bladder cancer.

  1999cited by this paper
• Telomerase activity in human renal cell carcinoma

  1999cited by this paper
• Initial evaluation of the diagnostic performance of the new urinary bladder cancer antigen test as a tumor marker for transitional cell carcinoma of the bladder.

  1999cited by this paper
• Elevated urinary fibronectin levels after transurethral resection of bladder tumour: a possible role in patients failing therapy with bacillus Calmette–Guérin

  1999cited by this paper
• Correlation and prognostic significance of p53, p21WAF1/CIP1 and Ki-67 expression in patients with superficial bladder tumors treated with bacillus Calmette-Guerin intravesical therapy.

  1999cited by this paper
• Expression of early growth response genes in human prostate cancer.

  1998cited by this paper
• Detection of human telomerase reverse transcriptase messenger RNA in voided urine samples as a useful diagnostic tool for bladder cancer.

  1998cited by this paper
• A survey of telomerase activity in human cancer.

  1997cited by this paper
• Effect of pH and ionic strength on the spectrophotometric assessment of nucleic acid purity.

  1997cited by this paper
• Clinical implications of telomerase in cancer.

  1997cited by this paper
• Telomerase activity in normal and malignant mammalian tissues: feasibility of telomerase as a target for cancer chemotherapy.

  1997cited by this paper
• Fluorometric assay for DNA polymerases and reverse transcriptase.

  1996cited by this paper
• Telomerase activity in human germline and embryonic tissues and cells.

  1996cited by this paper
• Telomeres and telomerase in normal and malignant haematologic cells.

  1996cited by this paper
• Intravesical bacillus Calmette-Guérin therapy prevents tumor progression and death from superficial bladder cancer: ten-year follow-up of a prospective randomized trial.

  1995influential reference
• Bacillus Calmette-Guérin in superficial bladder cancer: consensus and controversies.

  1995cited by this paper
• Low grade transitional cell carcinoma of the bladder. Cytologic Diagnosis by Key Features as Identified by Logistic Regression Analysis

  1994cited by this paper
• Transitional cell carcinoma of the bladder.

  1994influential reference
• Urinary fibronectin in diagnosis and follow-up of patients with urinary bladder cancer.

  1993cited by this paper
• Kinetic PCR Analysis: Real-time Monitoring of DNA Amplification Reactions

  1993influential reference
• Dot-dye-immunoassay and dot-ELISA for the serological differentiation of acute and chronic schistosomiasis mansoni using keyhole limpet haemocyanin as antigen.

  1993cited by this paper
• Prospective randomized comparison of intravesical with percutaneous bacillus Calmette-Guerin versus intravesical bacillus Calmette-Guerin in superficial bladder cancer.

  1991cited by this paper
• Detection of specific polymerase chain reaction product by utilizing the 5'----3' exonuclease activity of Thermus aquaticus DNA polymerase.

  1991cited by this paper
• Avoiding false positives with PCR

  1989cited by this paper
• Choice of an optimal diluent for intravesical bacillus Calmette-Guerin administration.

  1989cited by this paper
• Superficial bladder cancer treated with bacillus Calmette-Guerin: a multivariate analysis of factors affecting tumor progression.

  1989cited by this paper
• Isolation and characterization of a fibronectin receptor from Staphylococcus aureus.

  1987cited by this paper
• The mechanism of human bladder tumor implantation in an in vitro model.

  1986cited by this paper
• Primary structure of human fibronectin: differential splicing may generate at least 10 polypeptides from a single gene.

  1985cited by this paper
• Tumor invasion and the extracellular matrix.

  1983cited by this paper
• Spectrophotometric and kinetics investigation of the Berthelot reaction for the determination of ammonia

  1977cited by this paper

• No citing papers are available for this paper.